Trial Profile
A MULTI - CENTER OPEN LABEL PHASE II (B) STUDY TO ASSESS EFFECTS OF SOM230 ON CARDIOVASCULAR PARAMETERS IN ACROMEGALIC PATIENTS
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2016
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- 27 Sep 2016 New trial record